Clinical trial
Intravenous vs. Intracoronary Use of Abciximab
NCT00685464 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous vs. Intracoronary Use of Abciximab
- Lead sponsor
- University Hospital, Gentofte, Copenhagen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- December 31, 2009
- Enrollment
- 355 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, ischemic heart disease